Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3254

Actual shortage: 238 (7%)
Anticipated shortage: 6 (0%)
Avoided shortage: 9 (0%)
Resolved: 3001 (92%)

Discontinuation Reports

355

To be discontinued: 22 (6%)
Discontinued: 333 (94%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-PANTOPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2021-12-03 2022-02-14 150435
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2021-12-24 2022-04-14 151886
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-01-21 2022-03-14 153282
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-01-28 2022-03-24 153786
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2022-09-01 2022-09-16 168359
APO-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-09-01 2022-10-31 168364
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2022-09-09 2022-09-30 169060
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2023-02-02 2023-02-23 183492
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2023-02-09 2023-02-23 184106
APO-PANTOPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2023-03-02 2023-04-27 185936
APO-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2023-03-30 2023-08-23 188427
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2023-06-09 2023-07-27 194568
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2023-11-06 2024-02-09 209342
APO-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2023-11-10 2023-12-08 209951
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2023-12-01 2024-02-09 212365
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2024-02-23 2024-03-22 220459
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-04-12 2024-04-19 224984
APO-PANTOPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-05-03 2024-05-31 227034
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-05-03 2024-05-31 227073
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2024-06-06 2024-10-18 229776

Showing 2881 to 2900 of 3254

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-AMOXI 250MG CAPSULE Discontinued 2018-09-07 2019-02-13 60171
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399

Showing 41 to 60 of 355